article thumbnail

Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association

Circulation

The field of cardio-oncology has expanded over the past 2 decades to address the ever-increasing issues related to cardiovascular disease in patients with cancer and survivors.

Cancer 55
article thumbnail

Researchers Link Infant Heart Defects, Childhood Cancer

DAIC

tim.hodson Mon, 03/17/2025 - 14:56 March 17, 2025 Being born with a heart defect may be associated with an increased cancer risk for babies and their moms, according to new research published today in the American Heart Associations flagship journal Circulation. are forms of congenital heart defects (CHD).

Cancer 52
article thumbnail

Ochsner Children’s Hospital Advocates to Close the Gap in Pediatric Heart Care

DAIC

Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices. Yet, research and innovation in this field has not kept pace.

article thumbnail

Venous Thromboembolism Incidence Low in Pediatric Cancer Patients with COVID-19

HCPLive

Findings of a new study suggest COVID-19 does not serve as risk factor for the development of VTE in pediatric cancer patients.

article thumbnail

Top Specialties in Fellowship Programs and What They Offer: An In-depth Look for Medical Professionals

ADN Center of Excellence

Oncology Oncology fellowships are critical for those interested in addressing cancer, one of the most challenging and impactful diseases of our time. Fellows engage in diagnosing, treating, and researching cancers, gaining hands-on experience with cutting-edge treatments and therapies.

Cancer 59
article thumbnail

Growth Hormone Somatropin is Effective, Does Not Increase Cancer or Diabetes Risk

HCPLive

of pediatric patients had adverse events suspected to be caused by the injection. The biosimilar recombinant human growth hormone, somatropin, was found to be well-tolerated; only 1.6%

Cancer 59
article thumbnail

CanCHD Study of Hematopoietic Cancers in Children With and Without Genetic Syndromes

Journal of the American Heart Association

BackgroundIndividuals with genetic syndromes can manifest both congenital heart disease (CHD) and cancer attributable to possible common underlying pathways. To date, reliable risk estimates of hematopoietic cancer (HC) among children with CHD based on large population‐based data remain scant. Of them, 8.6% 95% CI, 11.7–15.1]).

Cancer 40